Emory University (US) finds little difference between percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass graft (CABG)
This article was originally published in Clinica
Executive Summary
Emory University (US) researchers say there is little difference in either cost or quality of life between angioplasty and bypass patients after three years. Angioplasty's initial cost-advantage "is largely, although probably not completely lost," says William Weintraub, writing in Circulation (November).